Liisa Bayko
Equibles does not estimate personal net worth.
Get an email with a short summary when Kalaris Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get KLRS alertsAbout Liisa Bayko
Liisa Bayko is recorded as CFO at Kalaris Therapeutics, Inc. (KLRS) since July 20, 2026. Kalaris Therapeutics, Inc. reported in an 8-K filed July 20, 2026 that Liisa Bayko was appointed Chief Financial Officer and Treasurer, effective July 20, 2026. Kalaris Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kalaris Therapeutics, Inc. includes Andrew Oxtoby (CEO and Board Member), Diana M. Brainard (CEO and Board Member), Vikas Sinha (CEO) and 7 others.
“On July 16, 2026, the Board of Directors (the “Board”) of Kalaris Therapeutics, Inc. (the “Company”) appointed Liisa Bayko as Chief Financial Officer and Treasurer of the Company, effective as of July 20, 2026 (the “Effective Date”).”
Affiliation history
-
Current
2026-07-20–present
Company network
Leadership on record at Kalaris Therapeutics, Inc.
- Andrew Oxtoby CEO, Board Member
- Diana M. Brainard CEO, Board Member
- Vikas Sinha CEO
- David Hallal Chairman, Board Member
- Brett Hagen CFO
- Matthew Gall CFO
- Amy Vandekop Chief Accounting Officer
- Anthony Adamis Board Member
- Derek Adams, Ph.D. Board Member
- Laurie Keating Board Member